Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Por um escritor misterioso
Descrição
Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors
Cipargamin - an overview
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC
Compounds 1a-c and 2a-b bind in the Plasmodium NMT peptide binding
The NMT recognition site is characterized by four distinct pockets, a
Frontiers Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
Structure of the N-terminal region of ScNMT. A, molecular surface of
ACS Infectious Diseases
Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC
de
por adulto (o preço varia de acordo com o tamanho do grupo)